Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Food Funct ; 14(24): 10977-10990, 2023 Dec 11.
Artigo em Inglês | MEDLINE | ID: mdl-38014521

RESUMO

Pectin, a kind of dietary fiber, has attracted much attention owing to its beneficial effect on human health in recent years. In this study, the effects of both 'Ganzhou' navel orange peel pectin (GOP) and modified GOP (MGOP) on type 2 diabetes (T2DM) were investigated. The results indicated that GOP and MGOP intervention had positive effects on T2DM in C57BL/6 mice. After modification, pectin can be changed into low methoxy pectin (LMP) and the content of GalA can increase, which endow MGOP with significant effects on improving lipid metabolism (TC, TG, and LDL-C decreased by 30.46%, 50%, and 37.56%, respectively, and HDL-C increased by 56%) and OGTT, further reducing insulin resistance (insulin decreased by 74.35%). In addition, MGOP was superior to GOP in improving oxidative stress (GSH and GSH-Px increased by 52.05% and 29.08% respectively, and MDA decreased by 84.02%), inhibiting inflammation and promoting SCFA synthesis. 16S rRNA analysis showed that MGOP changed the composition of intestinal microbiota in diabetic mice, decreased the abundance of Alistipes, Helicobacter and Oscillibacter, and increased the relative abundance of Dubosiella, Akkermansiaceae, and Atopobiaceae. The phenotypes of the gut microbiome also changed accordingly, which showed that MGOP significantly inhibited the growth of Gram-negative bacteria and potential pathogenic bacteria and reversed the related complications. Taken together, our findings revealed that MGOP intake regulated lipid metabolism and oxidative stress and improved the gut health of mice, with promising effects against T2DM and related complications.


Assuntos
Citrus sinensis , Diabetes Mellitus Experimental , Diabetes Mellitus Tipo 2 , Microbioma Gastrointestinal , Humanos , Camundongos , Animais , Pectinas/farmacologia , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/microbiologia , RNA Ribossômico 16S , Camundongos Endogâmicos C57BL
2.
Int J Biol Macromol ; 242(Pt 2): 124865, 2023 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-37207756

RESUMO

This study aimed to investigate the mechanisms of nature and modified 'Guanximiyou' pummelo peel pectin (GGP and MGGP) in alleviating T2DM through in vitro and in vivo. After modification, pectin was transformed from high methoxy pectin (HMP) to low methoxy pectin (LMP), and the content of galacturonic acid was increased. These made MGGP have stronger antioxidant capacity and better inhibition effect on corn starch digestion in vitro. In vivo experiments have shown that both GGP and MGGP inhibited the development of diabetes after 4 weeks of ingestion. However, MGGP can more effectively reduce blood glucose and regulate lipid metabolism, and has significant antioxidant capacity and the ability to promote SCFAs secretion. In addition, 16S rRNA analysis showed that MGGP changed the composition of intestinal microbiota in diabetic mice, decreased the abundance of Proteobacteria, and increased the relative abundance of Akkermansia, Lactobacillus, Oscillospirales and Ruminococcaceae. The phenotypes of the gut microbiome also changed accordingly, indicating that MGGP can inhibit the growth of pathogenic bacteria, alleviate intestinal functional metabolic disorders and reverse the potential risk of related complications. Altogether, our findings demonstrate that MGGP, as a dietary polysaccharide, may inhibit the development of diabetes by reversing the imbalance of gut microbiota.


Assuntos
Diabetes Mellitus Experimental , Diabetes Mellitus Tipo 2 , Microbioma Gastrointestinal , Camundongos , Animais , Pectinas/farmacologia , Pectinas/metabolismo , Diabetes Mellitus Experimental/tratamento farmacológico , RNA Ribossômico 16S/genética , Antioxidantes/farmacologia , Diabetes Mellitus Tipo 2/tratamento farmacológico
3.
Molecules ; 26(21)2021 Nov 05.
Artigo em Inglês | MEDLINE | ID: mdl-34771105

RESUMO

To evaluate the important Vitis amurensis germplasm, the quality characteristics and anthocyanin profiles of the ripe berries of 20 V. amurensis grapes and 11 interspecific hybrids in two consecutive years were analysed. Compared with the V. vinifera grapes, V. amurensis grapes had small berries with low total soluble solids and high titratable acids, and were richer in phenolic compounds except for flanan-3-ols in their skins but had lower phenolic contents in their seeds and showed lower antioxidant activities. An outstanding feature of the V. amurensis grapes was their abundant anthocyanin contents, which was 8.18-fold higher than the three wine grapes of V. vinifera. The anthocyanin composition of V. amurensis was characterized by an extremely high proportion of diglucoside anthocyanins (91.71%) and low acylated anthocyanins (0.04%). Interestingly, a new type of speculated 3,5,7-O-triglucoside anthocyanins was first identified and only detected in V. amurensis grapes and hybrids. Based on the total phenolic and anthocyanin characteristics, V. amurensis grapes were set apart from V. vinifera cultivars and the interspecific hybrids, for the same qualities, fell between them, as assessed by principal component analysis.


Assuntos
Antocianinas/análise , Antocianinas/química , Sementes/química , Vitis/química , Antioxidantes/química , Antioxidantes/farmacologia , Compostos Fitoquímicos/análise , Compostos Fitoquímicos/química , Extratos Vegetais , Análise de Componente Principal
4.
Food Funct ; 6(3): 834-41, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25599885

RESUMO

The present study investigated the anti-obesity and anti-diabetic effects of kaempferol glycoside (KG) fractions which were composed of four kaempferol glycosides and purified from unripe Jindai-soybean (Edamame) leaves in C57BL/6J mice. High fat-fed mice treated with 0.15% dietary KG for 92 days had reduced body weight, adipose tissue and TG levels compared to the high fat-fed control group. KG-treatment also decreased fasting blood glucose, serum HbA1c (hemoglobin A(1c)) levels and improved insulin resistance. Gene expression analysis of the liver showed that KG decreased peroxisome proliferator-activated receptor (PPAR-γ) and sterol regulatory element-binding protein (SREBP-1c) expression. These results suggest that KG reduced the accumulation of adipose tissue, improving hyperlipidemia as well as diabetes in obese mice by increasing lipid metabolism through the downregulation of PPAR-γ and SREBP-1c. Thus, KG may have an anti-obesity and anti-diabetic potential.


Assuntos
Fármacos Antiobesidade/uso terapêutico , Suplementos Nutricionais , Glycine max/química , Hipoglicemiantes/uso terapêutico , Quempferóis/uso terapêutico , Obesidade/prevenção & controle , Folhas de Planta/química , Adiposidade , Animais , Fármacos Antiobesidade/análise , Fármacos Antiobesidade/química , Fármacos Antiobesidade/isolamento & purificação , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/etiologia , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/prevenção & controle , Dieta Hiperlipídica/efeitos adversos , Suplementos Nutricionais/análise , Hemoglobinas Glicadas/análise , Glicosídeos/análise , Glicosídeos/química , Glicosídeos/isolamento & purificação , Glicosídeos/uso terapêutico , Humanos , Hipertrigliceridemia/complicações , Hipertrigliceridemia/etiologia , Hipertrigliceridemia/metabolismo , Hipertrigliceridemia/prevenção & controle , Hipoglicemiantes/análise , Hipoglicemiantes/química , Hipoglicemiantes/isolamento & purificação , Hipolipemiantes/análise , Hipolipemiantes/química , Hipolipemiantes/isolamento & purificação , Hipolipemiantes/uso terapêutico , Resistência à Insulina , Quempferóis/análise , Quempferóis/química , Quempferóis/isolamento & purificação , Metabolismo dos Lipídeos , Masculino , Camundongos Endogâmicos C57BL , Obesidade/complicações , Obesidade/etiologia , Obesidade/metabolismo , Extratos Vegetais/química , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/uso terapêutico , Folhas de Planta/crescimento & desenvolvimento , Distribuição Aleatória , Glycine max/crescimento & desenvolvimento
5.
Biosci Biotechnol Biochem ; 75(9): 1677-84, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21897048

RESUMO

The anti-diabetic effects of a kaempferol glycoside-rich fraction (KG) prepared from leaves of unripe Jindai soybean (Edamame) and kaempferol, an aglycone of kaempferol glycoside, were determined in genetically type 2 diabetic KK-A(y) mice. The hemoglobin A(1c) level was decreased and tended to be decreased by respectively feeding KG and kaempferol (K). The area under the curve (AUC) in the oral glucose tolerance test (OGTT) tended to be decreased by feeding K and KG. The liver triglyceride level and fatty acid synthase activity were both decreased in the mice fed with KG and K when compared to those parameters in the control mice. These results suggest that KG and K would be useful to improve the diabetes condition. The major flavonoids in KG were identified as kaempferol 3-O-ß-D-glucopyranosyl(1→2)-O-[α-L-rhamnopyranosyl(1→6)]-ß-D-galactopyranoside, kaempferol 3-O-ß-D-glucopyranosyl(1→2)-O-[α-L-rhamnopyranosyl(1→6)]-ß-D-glucopyranoside, kaempferol 3-O-ß-D-(2-O-ß-D-glucopyranosyl) galactopyranoside and kaempferol 3-O-ß-D-(2,6-di-O-α-L-rhamnopyranosyl) galactopyronoside, suggesting that these compounds or some of them may be concerned with mitigation of diabetes.


Assuntos
Diabetes Mellitus Tipo 2 , Glycine max/química , Glicosídeos/farmacologia , Hipoglicemiantes/farmacologia , Quempferóis/farmacologia , Extratos Vegetais/farmacologia , Adiponectina/sangue , Animais , Glicemia/análise , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/fisiopatologia , Modelos Animais de Doenças , Teste de Tolerância a Glucose , Glicosídeos/química , Glicosídeos/uso terapêutico , Hipoglicemiantes/química , Hipoglicemiantes/uso terapêutico , Insulina/sangue , Quempferóis/química , Quempferóis/uso terapêutico , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Extratos Vegetais/química , Extratos Vegetais/uso terapêutico , Folhas de Planta/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA